Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8206)
All Articles published online
|
Publishing Process of This Article
|
Apr 10, 2017 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ghosn M, El Rassy E, Kourie HR. Immunotherapies in sarcoma: Updates and future perspectives. World J Clin Oncol 2017; 8(2): 145-150 [PMID: 28439495 DOI: 10.5306/wjco.v8.i2.145] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v8/i2/145.htm |
| Number | Citing Articles |
| 1 |
Denise Garcia, Patrick Nasarre, Ingrid V. Bonilla, Eleanor Hilliard, Yuri K. Peterson, Laura Spruill, Anne-Marie Broome, Elizabeth G. Hill, Jason T. Yustein, Shikhar Mehrotra, Nancy Klauber-DeMore. Development of a Novel Humanized Monoclonal Antibody to Secreted Frizzled-Related Protein-2 That Inhibits Triple-Negative Breast Cancer and Angiosarcoma Growth In Vivo. Annals of Surgical Oncology 2019; 26(13): 4782 doi: 10.1245/s10434-019-07800-2
|
| 2 |
Chuanxi Zheng, Wei You, Peng Wan, Xiaochun Jiang, Jinquan Chen, Yuchen Zheng, Wei Li, Jifeng Tan, Shiquan Zhang. Clinicopathological and prognostic significance of PD-L1 expression in sarcoma. Medicine 2018; 97(25): e11004 doi: 10.1097/MD.0000000000011004
|
| 3 |
Zhenhua Zhu, Zheng Jin, Mei Zhang, Yajun Tang, Guang Yang, Xiaowei Yuan, Jihang Yao, Dahui Sun. Prognostic value of programmed death-ligand 1 in sarcoma: a meta-analysis. Oncotarget 2017; 8(35): 59570 doi: 10.18632/oncotarget.19168
|
| 4 |
Jenna S. Bleloch, Reyna D. Ballim, Serah Kimani, Jeannette Parkes, Eugenio Panieri, Tarryn Willmer, Sharon Prince. Managing sarcoma: where have we come from and where are we going?. Therapeutic Advances in Medical Oncology 2017; 9(10): 637 doi: 10.1177/1758834017728927
|
| 5 |
Jing Zhang, Maoshan Chen, Yuanyuan Zhao, Huihua Xiong, Tal Sneh, Yang Fan, Jianhua Wang, Xiao Zhou, Chen Gong. Complement and coagulation cascades pathway correlates with chemosensitivity and overall survival in patients with soft tissue sarcoma. European Journal of Pharmacology 2020; 879: 173121 doi: 10.1016/j.ejphar.2020.173121
|
| 6 |
Aina Angelina, Nurjati Chairani Siregar, Riesye Arisanty. Wilms’ tumor 1 protein expression in embryonal and alveolar rhabdomyosarcoma and its association with clinical prognostic factors: a cross-sectional study. Medical Journal of Indonesia 2020; 29(1): 47 doi: 10.13181/mji.oa.193326
|
| 7 |
Efstathios T Pavlidis, Theodoros E Pavlidis. New trends in the surgical management of soft tissue sarcoma: The role of preoperative biopsy. World Journal of Clinical Oncology 2023; 14(2): 89-98 doi: 10.5306/wjco.v14.i2.89
|
| 8 |
Tadashi Kondo. Current status of proteomics of soft tissue sarcomas. Expert Review of Proteomics 2017; 14(12): 1131 doi: 10.1080/14789450.2017.1394190
|
| 9 |
Sumana Narayanan, Joseph J. Skitzki. Cancer Immunology. 2020; : 363 doi: 10.1007/978-3-030-57949-4_15
|
| 10 |
Yitian Wang, Jian Zhu, Wei Yu, Junjie Wang, Kaishun Xia, Chengzhen Liang, Huimin Tao. Allogenic γδ T cell and tumor cell fused vaccine for enhanced immunotherapeutic efficacy of osteosarcoma. Journal of Bone Oncology 2020; 21: 100214 doi: 10.1016/j.jbo.2018.100214
|